Subclinical Avian Influenza A(H5N1) Virus Infection in Human, Vietnam
Mai Quynh Le

, Peter Horby, Annette Fox, Hien Tran Nguyen, Hang Khanh Le Nguyen, Phuong Mai Vu Hoang, Khanh Cong Nguyen, Menno D. de Jong, Rienk E. Jeeninga, H. Rogier van Doorn, Jeremy Farrar, and Heiman F.L. Wertheim
Author affiliations: National Institute of Hygiene and Epidemiology, Hanoi, Vietnam (M.Q.Le, H.T. Nguyen, H.K.L. Nguyen, P.M.V. Hoang, K.C. Nguyen); Wellcome Trust Major Overseas Programme, Hanoi and Ho Chi Minh City, Vietnam (P. Horby, A. Fox, M.D. de Jong, H.R. van Doorn, J. Farrar, H.F.L. Wertheim); Centre for Tropical Medicine, Oxford, United Kingdom (P. Horby, A. Fox, H.R. van Doorn, J. Farrar, H.F.L. Wertheim); Academic Medical Center, Amsterdam, the Netherlands (M.D. de Jong, R.E. Jeeninga)
Main Article
Table 1
HHI and MN assay titers for serum samples from woman with subclinical influenza A(H5N1) virus infection, Vietnam, 2011
Clade and sample
|
HHI
|
MN
|
Clade 1 |
|
|
First sample, day 5 |
<20 |
ND |
Second sample, day 11 |
40 |
<10 |
Third sample, day 41
|
40
|
<10
|
Clade 2.3.2.1 |
|
|
First sample, day 5 |
<20 |
ND |
Second sample, day 11 |
80 |
80 |
Third sample, day 41
|
160
|
160
|
Clade 2.3.4 |
|
|
First sample, day 5 |
<20 |
ND |
Second sample, day 11 |
80 |
40 |
Third sample, day 41 |
160 |
40 |
Main Article
Page created: September 16, 2013
Page updated: September 16, 2013
Page reviewed: September 16, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.